Followers | 14 |
Posts | 1731 |
Boards Moderated | 0 |
Alias Born | 04/07/2014 |
Thursday, May 23, 2019 7:01:35 AM
Why is there always "additional information" requested of BIEL during the FDA clearance process? Is the culprit the FDA, or is it BIEL? Though it's JMO, but I would tag the latter. By now, wouldn't a reasonable person think BIEL should know exactly what data/information the FDA expects to receive, in order to give clearance? This is ludicrous folks! BIEL has at least one PHD on staff who is intricately involved in the development of their product, and they can't figure out what to provide to the FDA to obtain clearance. Something is seriously wrong here folks!!
GLTA!!!
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM